Guangdong Hybribio Biotech Co Ltd (300639) — Cash Flow Quality Index
Guangdong Hybribio Biotech Co Ltd (300639) has a Cash Flow Quality Index of 2.40x as of September 2023. Operating cash flow of CN¥118.07 Million exceeds net income of CN¥49.26 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Guangdong Hybribio Biotech Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Hybribio Biotech Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guangdong Hybribio Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Guangdong Hybribio Biotech Co Ltd. For live market cap and the full company financial profile, see how much is Guangdong Hybribio Biotech Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.28x | CN¥319.60 Million | CN¥140.47 Million | ▲ +213.0% |
| 2022 | 0.73x | CN¥1.31 Billion | CN¥1.80 Billion | ▲ +1.9% |
| 2021 | 0.71x | CN¥631.34 Million | CN¥884.94 Million | ▼ -9.6% |
| 2020 | 0.79x | CN¥311.30 Million | CN¥394.66 Million | ▼ -4.3% |
| 2019 | 0.82x | CN¥112.83 Million | CN¥136.96 Million | ▲ +9.4% |
| 2018 | 0.75x | CN¥80.39 Million | CN¥106.74 Million | ▼ -12.7% |
| 2017 | 0.86x | CN¥79.17 Million | CN¥91.76 Million | ▲ +1.1% |
| 2016 | 0.85x | CN¥63.63 Million | CN¥74.56 Million | ▲ +13.4% |
| 2015 | 0.75x | CN¥48.47 Million | CN¥64.42 Million | ▲ +37.8% |
| 2014 | 0.55x | CN¥34.65 Million | CN¥63.46 Million | ▼ -30.4% |
| 2013 | 0.78x | CN¥22.89 Million | CN¥29.17 Million | ▼ -3.8% |
| 2012 | 0.82x | CN¥16.08 Million | CN¥19.73 Million | — |